138 related articles for article (PubMed ID: 19170268)
1. New bisphosphonates and trends in drug therapy for osteoporosis: preface.
Matsumoto T
Clin Calcium; 2009 Jan; 19(1):9. PubMed ID: 19170268
[No Abstract] [Full Text] [Related]
2. [Bisphosphonates for osteoporosis].
Narusawa K; Nakamura T
Nihon Rinsho; 2007 Nov; 65 Suppl 9():311-5. PubMed ID: 18161123
[No Abstract] [Full Text] [Related]
3. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
[No Abstract] [Full Text] [Related]
4. [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].
MMW Fortschr Med; 2006 Jun; 148(25):60-1. PubMed ID: 16859169
[No Abstract] [Full Text] [Related]
5. Corticosteroids: no drug prevention of fractures needed.
Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
[TBL] [Abstract][Full Text] [Related]
6. [Osteoporosis therapy. Bisphosphonates compared].
MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
[No Abstract] [Full Text] [Related]
7. [New development in bisphosphonate treatment. Characteristics and effectiveness of intermittent bisphophonates].
Okazaki R
Clin Calcium; 2009 Jan; 19(1):30-6. PubMed ID: 19122262
[TBL] [Abstract][Full Text] [Related]
8. [Evidence and utility of etidronate for the treatment of osteoporosis].
Takada J; Iba K; Yamashita T; Yoshizaki T
Clin Calcium; 2008 Oct; 18(10):1427-33. PubMed ID: 18830039
[TBL] [Abstract][Full Text] [Related]
9. [New development in bisphosphonate treatment. Fracture prevention by bisphosphonates].
Hosoi T
Clin Calcium; 2009 Jan; 19(1):11-8. PubMed ID: 19122260
[TBL] [Abstract][Full Text] [Related]
10. [Routine osteoporosis therapy].
Ringe JD
Krankenpfl J; 2004; 42(7-10):233. PubMed ID: 15675395
[No Abstract] [Full Text] [Related]
11. FPIN's clinical inquiries. Combination therapy for postmenopausal osteoporosis.
Howard E; Tagliarino-Jones H
Am Fam Physician; 2010 Feb; 81(4):439. PubMed ID: 20148496
[No Abstract] [Full Text] [Related]
12. [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)].
Adachi JD
MMW Fortschr Med; 2004 Aug; 146(31-32):53. PubMed ID: 15529719
[No Abstract] [Full Text] [Related]
13. Bisphosphonates and atypical femoral fractures: a time for reflection.
Compston JE
Maturitas; 2010 Jan; 65(1):3-4. PubMed ID: 19932574
[No Abstract] [Full Text] [Related]
14. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
Fukunaga M
Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
[TBL] [Abstract][Full Text] [Related]
15. [Patient compliance program aids therapy success].
MMW Fortschr Med; 2009 Mar; 151(11):47. PubMed ID: 19469207
[No Abstract] [Full Text] [Related]
16. [Treatment with bisphosphonates and previous dental health].
Madrid C; Bouferrache K; Jaques B; Broome M
Rev Med Suisse; 2009 Apr; 5(200):909-10; author reply 910-1. PubMed ID: 19438092
[No Abstract] [Full Text] [Related]
17. [Concurrent treatment of osteoporosis including vitamin K].
Kobayashi S; Shiraki M; Takaoka K
Clin Calcium; 2007 Nov; 17(11):1731-7. PubMed ID: 17982194
[TBL] [Abstract][Full Text] [Related]
18. [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
Ringe JD
MMW Fortschr Med; 2009 Mar; 151(10):7. PubMed ID: 19472655
[No Abstract] [Full Text] [Related]
19. [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis].
Takeuchi Y
Clin Calcium; 2009 Jan; 19(1):85-90. PubMed ID: 19122268
[TBL] [Abstract][Full Text] [Related]
20. [Effects of concurrent therapy for patients with osteoporosis].
Kobayashi S; Shiraki M; Takaoka K
Clin Calcium; 2005 Apr; 15(4):661-5. PubMed ID: 15802781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
